Diabetes decisions — 2025

The Board denied increased ratings for peripheral neuropathy and remanded claims related to eye conditions and TDIU.

The Board granted service connection for diabetes mellitus type 2 and prostate cancer, finding a causal relationship between the Veteran's in-service exposure to defoliant agents and these conditions.

The Board remands the claims for service connection for diabetes mellitus type II, trigeminal neuralgia, and intraocular melanoma tumor of the right eye due to contaminated water exposure at Camp Lejeune for a new VA etiology opinion.

The Board denied the appeal, affirming the severance of service connection for various conditions due to clear and unmistakable errors in the prior decision.

The Board granted service connection for diabetes, ischemic heart disease, hypertension, and neuropathy of the right and left upper and lower extremities as secondary to diabetes due to herbicide exposure during the Veteran's service in Okinawa.

The Veteran was granted an effective date of July 29, 2024, for Dependents' Educational Assistance (DEA), but other claims for increased ratings and TDIU were denied.

The Board denied the Veteran's claim for an initial evaluation in excess of 20 percent for diabetes, as the evidence did not support a higher rating.

The Board granted the application to readjudicate the claims for service connection for diabetes mellitus, type II, hypertension, and erectile dysfunction based on new and relevant evidence.

All four service connection claims are remanded for further development. The AOJ must conduct radiation dose estimation for the bladder cancer claim and obtain adequate medical opinions regarding the etiology of diabetes mellitus type II and progressive supranuclear ophthalmoplegia.

The Board denied initial disability ratings in excess of 70 percent for PTSD, 10 percent for bilateral hearing loss, and 30 percent for COPD with asthma. The claims for service connection for various disabilities were remanded.

The Board remands the issue of entitlement to service connection for diabetes mellitus type II due to a pre-decisional duty to assist error, requiring an adequate VA medical opinion with sufficient rationale.

The Board granted service connection for diabetes mellitus, type II with nausea and vomiting, hypertension, renal failure, blurred vision, and status post ventral hernia.

The Veteran's service-connected diabetes, peripheral neuropathy of the bilateral lower extremities, sleep apnea, bilateral hearing loss, and tinnitus rendered him unable to secure and follow a substantially gainful occupation from May 30, 2008 to prior to March 3, 2011.

The appeal for service-connected disability compensation for diabetes mellitus, type II was dismissed due to the Veteran's death.

The Board dismissed the appeals for service connection and increased rating due to untimely filings.

The Board granted earlier effective dates for the grants of service connection for diabetes mellitus, Type II, diabetic retinopathy, and diabetic nephropathy, as well as awards of service connection for various peripheral neuropathies and amputations.

The Veteran is granted an effective date of May 13, 2019, for the award of special monthly compensation (SMC) and a certificate of eligibility for assistance in acquiring specially adapted housing.

The Board remands the claim for further research to verify the Veteran's assertion of herbicide exposure at Taegu Air Force Base during his service period.

The Board granted service connection for coronary artery disease, diabetes mellitus type II, and hypertension based on the Veteran's exposure to petrochemicals and heavy metals while stationed at El Toro Marine Corps Air Station.

The Board denied an earlier effective date for the grant of service connection for diabetes mellitus, type II and also denied a higher rating for diabetes mellitus, type II.